These criteria align with those defined by Stanley and Baker [15]: hyperinsulinemia, hypo-ketonemia, low free fatty acids, and a hyperglycemic response to glucagon. Insulin is not always detectable during hypoglycemia; measurement of C-peptide, which has a longer half-life, can enhance diagnostic accuracy. The gene discussed is INS; the disease is Hypoglycemia.